Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group.

Multiple sclerosis (Houndmills, Basingstoke, England)

Volumn 2, Issue 3, 1996, Pages 142-156

  Syndulko, K ^a   Ke, D ^a   Ellison, G W ^a   Baumhefner, R W ^a   Myers, L W ^a   Tourtellotte, W W ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; EVALUATION; HUMAN; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STANDARD; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; CHRONIC DISEASE; CYCLOSPORINE; DOUBLE-BLIND METHOD; EVALUATION STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; PSYCHOMOTOR PERFORMANCE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0030252409     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859600200305     Document Type: Article

References (0)